ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

NCT06526546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 364

Last updated 2026-03-02

No results posted yet for this study

Summary

The (ADVENT LTO) is an observational, non-significant risk study to assess the progression of atrial fibrillation in subjects who received ablation treatment with either the FARAPULSE Pulsed Field Ablation System or thermal ablation in the ADVENT Trial.

Conditions

  • Paroxysmal Atrial Fibrillation

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Vivek Reddy · MOUNT SINAI HOSPITAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2025-12-08
Completion
2025-12-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06526546 on ClinicalTrials.gov